Kestra Advisory Services LLC Acquires 14,406 Shares of CVS Health Corporation $CVS

Kestra Advisory Services LLC lifted its holdings in CVS Health Corporation (NYSE:CVS – Free Report) by 18.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,555 shares of the pharmacy operator’s stock after acquiring an additional 14,406 shares during the period. Kestra Advisory Services LLC’s holdings in CVS Health were worth $8,017,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Elevation Wealth Partners LLC lifted its stake in shares of CVS Health by 41.8% during the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 105 shares in the last quarter. HBW Advisory Services LLC boosted its stake in shares of CVS Health by 3.5% in the third quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator’s stock valued at $292,000 after purchasing an additional 115 shares during the period. Apella Capital LLC grew its holdings in CVS Health by 1.7% during the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock valued at $724,000 after purchasing an additional 117 shares in the last quarter. Wellington Altus USA Inc. increased its stake in CVS Health by 13.3% during the 2nd quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after buying an additional 120 shares during the period. Finally, Childress Capital Advisors LLC lifted its holdings in CVS Health by 3.9% in the 3rd quarter. Childress Capital Advisors LLC now owns 3,497 shares of the pharmacy operator’s stock worth $300,000 after buying an additional 131 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $112.00 target price on shares of CVS Health in a research report on Wednesday, September 9th. Jefferies Financial Group reiterated a “buy” rating and issued a $103.00 price target on shares of CVS Health in a report on Wednesday, November 4th. Leerink Partners dropped their price objective on shares of CVS Health from $112.00 to $104.00 and set an “outperform” rating on the stock in a research note on Thursday, November 5th. Robert W. Baird set a $107.00 price objective on CVS Health in a research note on Thursday, August 6th. Finally, Truist Financial upped their price target on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Twenty-three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $108.25.

Get Our Latest Stock Analysis on CVS

Insider Buying and Selling

In other CVS Health news, EVP Prem Shah purchased 23,855 shares of the business’s stock in a transaction on Friday, November 6th. The stock was bought at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the acquisition, the executive vice president owned 88,516 shares of the company’s stock, valued at $7,425,607.24. The trade was a 36.89% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.85% of the company’s stock.

CVS Health Price Performance

NYSE CVS opened at $89.03 on Wednesday. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The firm has a market capitalization of $113.92 billion, a PE ratio of 10.36, a P/E/G ratio of 0.74 and a beta of 0.58. The company’s 50 day simple moving average is $90.12 and its 200 day simple moving average is $88.94. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66.

CVS Health (NYSE:CVS – Get Free Report) last released its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.65 by $0.44. The firm had revenue of $108.40 billion during the quarter, compared to the consensus estimate of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.60 earnings per share. As a group, equities research analysts forecast that CVS Health Corporation will post 8.25 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were paid a dividend of $0.6650 per share. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 3.0%. CVS Health’s dividend payout ratio (DPR) is currently 30.97%.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

About CVS Health

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Featured Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.